Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadratus Lumborum Block for postoperative pain after laparoscopic nephrectomy
2017-002254-37Phase 4Active
- Sponsor
- Tampere University Hospital
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in kidney cancer, sponsored by Tampere University Hospital. Primary endpoint: Cumulative postoperative opioid consumption. Started Sep 2017; status: active.
02
Drugs
ropivacaine
03
Conditions
kidney cancer
Beyond the preview
Go deeper on 2017-002254-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002254-37.